Probing the role of homomeric and heteromeric receptor interactions in TGF-beta signaling using small molecule dimerizers

Current Biology : CB
B R Stockwell, S L Schreiber

Abstract

Transforming growth factor Beta (TGF-Beta) arrests many cell types in the G1 phase of the cell and upregulates plasminogen activator inhibitor 1 (PAI-1). The type 1 (TGF-Beta RI) an II (TGF-Beta RII) TGF-Beta receptors mediate these and other effects of TGF-Beta on target cells. TGF-Beta initially binds to TGF-Beta RII and subsequently TGF-Beta RI is recruited to form a heteromeric complex. TGF-Beta RI phosphorylates the downstream effectors Smad2 and Smad3, leading to their translocation into the nucleus. Here, we explored the role of receptor oligomerization in TGF-Beta signaling. We constructed fusion proteins containing receptor cytoplasmic tails linked to binding domains for small-molecule dimerizers. In COS-1 cells, recruitment of a soluble TGF-Beta RII tail to a myristoylated TGF-Beta RI tail promoted Smad2 nuclear translocation. In mink lung cells, homo-oligomerization of a myristoylated TGF-Beta Ri tail in presence of a myristoylated TGF-Beta RII tail activated the PAI-1 promoter. Oligomerization of an acidic mutant of the TGF-Beta RI tail in absence of TGF-Beta RII activated the PAI-A promoter and inhibited the growth of mink lung cells. Non-toxic, small molecules designed to oligomerize cytoplasmic tails of TGF-Beta ...Continue Reading

References

May 23, 1995·Proceedings of the National Academy of Sciences of the United States of America·J ChenS L Schreiber
Nov 12, 1993·Science·D M SpencerG R Crabtree
Feb 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·F Chen, R A Weinberg
Jan 1, 1994·Vitamins and Hormones·C H BassingX F Wang
Jul 1, 1994·The Journal of Cell Biology·Y I HenisH F Lodish
Aug 4, 1994·Nature·J L WranaJ Massagué
Jul 2, 1993·Cell·F López-CasillasJ Massagué
May 14, 1996·Proceedings of the National Academy of Sciences of the United States of America·P J BelshawS L Schreiber
Jul 25, 1996·Biochemical and Biophysical Research Communications·O LetourneurM G Grütter
Jul 1, 1996·Current Biology : CB·D M SpencerS L Schreiber
Apr 25, 1997·The Journal of Biological Chemistry·R G WellsH F Lodish
May 23, 1997·The Journal of Biological Chemistry·M P de CaesteckerR J Lechleider
Jul 22, 1997·Proceedings of the National Academy of Sciences of the United States of America·S D LiberlesS L Schreiber
Oct 6, 1997·The EMBO Journal·A NakaoP ten Dijke

❮ Previous
Next ❯

Citations

Dec 6, 2001·Advanced Drug Delivery Reviews·S Brocchini
Feb 12, 2002·Bioorganic & Medicinal Chemistry·Brian N Cook, Carolyn R Bertozzi
Oct 24, 1998·Bioorganic & Medicinal Chemistry·S L Schreiber
Feb 18, 1999·Current Opinion in Chemical Biology·B L Drees
Oct 5, 2010·Molecular BioSystems·Lingyin LiLaura L Kiessling
Oct 21, 2005·Molecular Biology of the Cell·John R SilviusDonato Terrone
Nov 1, 2001·Annual Review of Cell and Developmental Biology·M A Shogren-KnaakK M Shokat
Feb 2, 2012·FEBS Letters·Marcelo EhrlichYoav I Henis
Oct 16, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Elena LenciAndrea Trabocchi
Mar 23, 2011·The EMBO Journal·Tao HuangAndrew P Hinck
May 16, 2012·FEBS Letters·Mateusz Putyrski, Carsten Schultz
Jul 25, 2008·The Journal of Craniofacial Surgery·Matthew D Kwan, Michael T Longaker
Oct 16, 1999·Nature·D OnichtchoukC Niehrs
Jan 29, 2002·The Journal of Biological Chemistry·Ana Kasirer-FriedeSanford J Shattil
May 22, 2020·Journal of Cell Science·Irène AmblardAlain Joliot
Jan 19, 2001·Angewandte Chemie·Prabhat AryaMyung-Gi Baek
Jan 16, 2015·Journal of Cell Science·Qian WangZhixiang Wang
Feb 14, 2002·Chemistry & Biology·Paul A ClemonsStuart L Schreiber
Aug 9, 2003·Journal of Medicinal Chemistry·Mookda PattarawarapanKevin Burgess
Oct 3, 2012·Organic Letters·Balakrishnan Rajarathinam, Gnanasambandam Vasuki
Dec 15, 2017·ACS Synthetic Biology·Yuchao LiZhike Zi
Jan 10, 2001·Journal of Combinatorial Chemistry·M PattarawarapanK Burgess
Jun 15, 2006·Chemical Reviews·Daniel P Walsh, Young-Tae Chang
Jul 18, 2001·Journal of the American Chemical Society·K KoideG L Verdine

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.